[X.com] by @cremieuxrecueil
The FDA has access to the data underlying antidepressant trials, they just don't publish it.
So the picture that laymen see when they look through the literature is rosy: antidepressants are great!
By contrast, the FDA sees a graveyard of weak or failed drugs.
Take a look: https://t.co/Ixgt7sF51J
Quoted Tweet:
Nicholas Fabiano, MD
@NTFabiano
Antidepressant efficacy is inflated by the cumulative impact of publication bias, outcome reporting bias, spin, and citation bias on the evidence base. 🧵1/12 https://t.co/UhkfAm7f6F
View original tweet
Mon Aug 04 14:35:29 +0000 2025